Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Collins has led the NIH under three presidents over more than 12 years.
The release of the “feel-good” hormone dopamine in the brain is actually triggered by both pleasurable and stressful experiences.
The study results, from 2019, precede the surge of overdose deaths during the COVID-19 pandemic.
Proteins found in the venom of this fearsome, furry spider may lead to potent, nonaddictive pain meds.
Addiction advocates stress that COVID-19 shifted the burden of the opioid epidemic to African-American communities.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.
Antiretroviral therapy helped people with the virus add years to their lives, but now scientists must address other issues of longevity.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.
Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.
A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.
It’s a lot easier to fight addiction when you have a stable place to live.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
A new report warns the crisis could see a third wave if synthetic opioids continue to move into new U.S. markets.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.